Oral contraceptives and cardiovascular outcomes: cause or bias? (Q34096073)

31 July 2017

1 reference

title

Oral contraceptives and cardiovascular outcomes: cause or bias? (English)

1 reference

31 July 2017

1 reference

Spitzer WO

1 reference

31 July 2017

publication date

1 August 2000

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

issue

2 Suppl

1 reference

31 July 2017

page(s)

3S-9S; discussion 37S-38S

1 reference

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

The risks of venous thromboembolic disease among German women using oral contraceptives: a database study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

First-time use of newer oral contraceptives and the risk of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Mortality in relation to smoking: 40 years' observations on male British doctors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

The use of beta-agonists and the risk of death and near death from asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

The 1995 pill scare revisited: anatomy of a non-epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Risk of venous thromboembolism in users of hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Case-control study of venous thromboembolism risk in users of hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Prospective study of exogenous hormones and risk of pulmonary embolism in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Could preferential prescribing and referral behaviour of physicians explain the elevated thrombosis risk found to be associated with third generation oral contraceptives?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Oral contraceptive switching patterns in the United Kingdom: an important potential confounding variable in studies of venous thromboembolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Utilization patterns of oral contraceptives in UK general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Selective prescribing of third generation oral contraceptives (OCs)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

The role of prescribing and referral bias in studies of the association between third generation oral contraceptives and increased risk of thromboembolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Oral contraceptives and venous thromboembolism. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Lowered risk of dying of heart attack with third generation pill may offset risk of dying of thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Risk of acute myocardial infarction and low-dose combined oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from international study on oral contraceptives and health of young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Stroke in users of low-dose oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Cerebral thrombosis and oral contraceptives. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Thrombotic diseases in young women and the influence of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

Oral contraceptives and venous thromboembolism: findings in a large prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2800%2900149-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-7824(00)00149-9

1 reference

31 July 2017

1 reference